Clinuvel Pharmaceuticals Limited has declared a fourth consecutive annual unfranked dividend of $0.025 per ordinary share following the financial results for the year ending 30 June 2021. The Company has previously issued unfranked dividends for the financial years ending 30 June 2020 and 2019 of $0.025 and 2018 of $0.02. Ex-dividend date is 02 September 2021, Record date is 03 September 2021 and Payment date is 17 September 2021.